Cytek Biosciences: With Growth, Low Debt, And A Positive Long-Term Outlook, Is It Undervalued?Seeking Alpha • 05/05/25
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025GlobeNewsWire • 04/29/25
Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025GlobeNewsWire • 04/24/25
Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro SystemGlobeNewsWire • 03/18/25
Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 OutlookGlobeNewsWire • 02/27/25
Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025GlobeNewsWire • 02/13/25
Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/02/25
Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare ConferenceGlobeNewsWire • 11/20/24
Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards ProgramGlobeNewsWire • 11/19/24
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell SorterGlobeNewsWire • 11/07/24
Cytek Biosciences, Inc. (CTKB) Q3 Earnings and Revenues Beat EstimatesZacks Investment Research • 11/05/24
Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and EuropeGlobeNewsWire • 09/18/24
Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing FacilityGlobeNewsWire • 08/21/24
Cytek Biosciences, Inc. (CTKB) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/06/24
Cytek Biosciences (CTKB) Moves 5.1% Higher: Will This Strength Last?Zacks Investment Research • 06/24/24
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare ConferenceGlobeNewsWire • 05/30/24